Form 4: Lilly Endowment Inc. Sells 12,974 Shares of Eli Lilly & Co.

Lilly Endowment Inc. sold 12,974 shares of Eli Lilly & Co. at a weighted average price of $804.184 per share on May 22, 2024.

Summary

• Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co., sold 12,974 shares of common stock on May 22, 2024.
• The shares were sold at a weighted average price of $804.184 per share.
• The sale was executed in multiple transactions with prices ranging from $804.00 to $804.65 per share.
• Following the transaction, Lilly Endowment Inc. beneficially owns 98,699,577 shares of Eli Lilly & Co.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by a major shareholder. It doesn't indicate positive or negative sentiment towards the company's performance.

Industry Context

This transaction is a routine disclosure of a significant shareholder's trading activity and does not necessarily indicate a change in the company's outlook or performance. It is common for large institutional investors to adjust their holdings periodically.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders and large shareholders in publicly traded companies.
• The sale by Lilly Endowment Inc. is similar to other large institutional investors adjusting their positions in response to market conditions or portfolio rebalancing.
• The transaction is within the normal range of trading activity for a company of Eli Lilly's size and market capitalization.

Stakeholder Impact

• The sale may have a minor impact on the stock price, but it is unlikely to significantly affect the company's operations or long-term prospects.
• Shareholders may be interested in the transaction as it provides insight into the trading activity of a major investor.

Key Dates

Keywords

Eli Lilly & Co, Lilly Endowment Inc, stock sale, share transaction, beneficial ownership, LLY